PROCTER & GAMBLE HEALTH
|
The Current P/B Ratio of PROCTER & GAMBLE HEALTH is 15.52.
| Share Price | ₹4,975.6 | Feb 13,2026 |
| Market Cap | ₹8,259.4 Cr | |
| Book Value | ₹532.1 Cr | Mar2025 - Standalone Results |
| Price/Book | 15.52x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of PROCTER & GAMBLE HEALTH
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹8,259.4 Cr] as on Feb 13,2026
(/) Book Value [ ₹532.1 Cr] based on Mar2025 - Standalone Results
(=) P/B Ratio [ 15.52x ]
Thus, for PROCTER & GAMBLE HEALTH , the investors are currently willing to pay '15.52 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of PROCTER & GAMBLE HEALTH !
The chart below summarizes the trend in P/B Ratio of PROCTER & GAMBLE HEALTH over the last five years.
Historical PB (Price/Book ) ratio chart of PROCTER & GAMBLE HEALTH
PB Ratio Performance Analysis for PROCTER & GAMBLE HEALTH
- PROCTER & GAMBLE HEALTH 's p/b ratio for fiscal years ending Mar2025 to Jun2022 averaged 13.95x.
- PROCTER & GAMBLE HEALTH 's operated at median p/b ratio of 14.75x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PROCTER & GAMBLE HEALTH 's p/b ratio peaked in Mar2025 at 16.04x.
- PROCTER & GAMBLE HEALTH 's p/b ratio hit its five-year low in Jun2022 of 11.41x.
How does PROCTER & GAMBLE HEALTH 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| PROCTER & GAMBLE HEALTH | 532.07 | 15.52 | 8,259.4 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 72,218.00 | 5.64 | 407,431.0 |
| DIVIS LABORATORIES LTD | 14,969.00 | 10.94 | 163,772.0 |
| CIPLA LTD | 31,079.30 | 3.46 | 107,503.0 |
| TORRENT PHARMACEUTICALS LTD | 7,590.69 | 18.16 | 137,884.0 |
| DR REDDYS LABORATORIES LTD | 33,404.90 | 3.17 | 105,798.0 |
| MANKIND PHARMA LTD | 14,288.70 | 5.95 | 85,050.2 |
| ZYDUS LIFESCIENCES LTD | 23,953.10 | 3.80 | 91,049.1 |
| LUPIN LTD | 17,119.50 | 5.87 | 100,496.0 |
| AUROBINDO PHARMA LTD | 32,653.30 | 2.04 | 66,705.1 |
| ABBOTT INDIA LTD | 4,204.27 | 13.38 | 56,246.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs PROCTER & GAMBLE HEALTH 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 2.04x |
| Max industry PB | 18.16x |
| Median industry PB | 5.87x |
| Average industry PB | 7.99x |
You may also like the below Video Courses